Diarrhea antibiotic: FDA panel backs fidaxomicin for - latimes.com
Links shared publicly online about this topic.
- 384total visits
Diarrhea antibiotic: FDA panel backs fidaxomicin for - latimes.com
View full resource at latimes.com
Tags: Diarrhea, Infection, Bacterial Infection, Diet and Nutrition, Drug, FDA, Antibiotic
Most Recently Shared on April 6, 2011 at 4:47 pm By:
Experts back new drug for diarrhea-causing bacterial infection http://lat.ms/fi0j3f
FDA Panel Gives New Antibiotic Fidaxomicin 2 Thumbs Up - QualityPoint Technologies
qualitypointtech.net — “Fidaxomicin, the novel antibiotic from Optimer Pharmaceuticals Inc, has been endorsed by the FDA--™s Anti-Infective Drugs Advisory Committee to treat Clostridium difficile-associated diarrhea. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on April 6, 2011 at 12:35 am By:
FDA Panel Gives New Antibiotic Fidaxomicin 2 Thumbs Up: Fidaxomicin, the novel antibiotic from Optimer Pharmaceuti... http://bit.ly/hiY4OX
FDA Panel Endorses Novel Antibiotic to treat C. Diff - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- SILVER SPRING, Md. -- An FDA advisory committee has voted unanimously to recommend approval of the investigational narrow-spectrum antibiotic fidaxomicin (Dificid), to treat Clostridium difficile-associated diarrhea.” View full resource at qualitypointtech.net
Most Recently Shared on April 5, 2011 at 9:35 pm By:
FDA Panel Endorses Novel Antibiotic to treat C. Diff: (MedPage Today) -- SILVER SPRING, Md. -- An FDA advisory com... http://bit.ly/gGoRjY
Medical News: FDA Panel to Weigh In on Novel Antibiotic for C. Diff - in Gastroenterology, General Gastroenterology from MedPage Today
medpagetoday.com — “WASHINGTON -- An investigational narrow-spectrum antibiotic appears to successfully treat Clostridium difficile-associated diarrhea and prevent it from coming back, FDA staff reviewers noted” View full resource at medpagetoday.com
Most Recently Shared on April 5, 2011 at 12:27 am By:
FDA Panel to Weigh In on Novel Antibiotic for C. Diff: WASHINGTON (MedPage Today) -- An… http://goo.gl/fb/FOOeM
Medical News: FDA Panel to Weigh In on Novel Antibiotic for C. Diff - in Gastroenterology, General Gastroenterology from MedPage Today
medpagetoday.com — “WASHINGTON -- An investigational narrow-spectrum antibiotic appears to successfully treat Clostridium difficile-associated diarrhea and prevent it from coming back, FDA staff reviewers noted” View full resource at medpagetoday.com
Most Recently Shared on April 4, 2011 at 11:41 pm By:
FDA Panel to Weigh In on Novel Antibiotic for C. Diff http://bit.ly/gCeAMa
Advertisement
